Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 OPA1 in multiple mitochondrial DNA deletion disorders.

Literature DB >> 19029523

OPA1 in multiple mitochondrial DNA deletion disorders.

J D Stewart¹, G Hudson, P Yu-Wai-Man, E L Blakeley, L He, R Horvath, P Maddison, A Wright, P G Griffiths, D M Turnbull, R W Taylor, P F Chinnery.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2008 PMID： 19029523 DOI： 10.1212/01.wnl.0000335931.54095.0a

Source DB: PubMed Journal: Neurology ISSN： 0028-3878 Impact factor: 9.910

Keyword Cloud
Cited

× No keyword cloud information.

15 in total

Review 1. The neuro-ophthalmology of mitochondrial disease.

Authors: J Alexander Fraser; Valérie Biousse; Nancy J Newman
Journal: Surv Ophthalmol Date: 2010-05-14 Impact factor: 6.048

2. Mitochondrial retention of Opa1 is required for mouse embryogenesis.

Authors: Billie A Moore; Gladys D Gonzalez Aviles; Christine E Larkins; Michael J Hillman; Tamara Caspary
Journal: Mamm Genome Date: 2010-07-21 Impact factor: 2.957

Review 3. Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors: Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal: Prog Retin Eye Res Date: 2010-11-26 Impact factor: 21.198

4. Multi-system neurological disease is common in patients with OPA1 mutations.

Authors: P Yu-Wai-Man; P G Griffiths; G S Gorman; C M Lourenco; A F Wright; M Auer-Grumbach; A Toscano; O Musumeci; M L Valentino; L Caporali; C Lamperti; C M Tallaksen; P Duffey; J Miller; R G Whittaker; M R Baker; M J Jackson; M P Clarke; B Dhillon; B Czermin; J D Stewart; G Hudson; P Reynier; D Bonneau; W Marques; G Lenaers; R McFarland; R W Taylor; D M Turnbull; M Votruba; M Zeviani; V Carelli; L A Bindoff; R Horvath; P Amati-Bonneau; P F Chinnery
Journal: Brain Date: 2010-02-15 Impact factor: 13.501

OPA1 in multiple mitochondrial DNA deletion disorders.

Review 1. The neuro-ophthalmology of mitochondrial disease.

2. Mitochondrial retention of Opa1 is required for mouse embryogenesis.

Review 3. Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

4. Multi-system neurological disease is common in patients with OPA1 mutations.

Review 5. Mitochondria and reactive oxygen species.

Review 6. POLG1-related and other "mitochondrial Parkinsonisms": an overview.

Review 7. Inherited eye-related disorders due to mitochondrial dysfunction.

Review 8. Disturbed mitochondrial dynamics and neurodegenerative disorders.

9. Secondary mtDNA defects do not cause optic nerve dysfunction in a mouse model of dominant optic atrophy.

Review 10. POLG-related disorders and their neurological manifestations.